Skip to main content

Table 3 Subgroup analyses for association between CHD and educational attainment

From: Educational attainment in patients with congenital heart disease: a comprehensive systematic review and meta-analysis

Subgroup

Number of studies (n CHD cases, n non-CHD)

OR (95% CI) for not achieving educational outcome per subgroup

Test for subgroup differences p value

Not obtaining a university degree

Geographic area

 Europe

8 (9871 vs. 93,221)

1.24 [1.03; 1.49]

0.03

 North America

1 (124 vs. 124)

1.49 [0.88; 2.52]

 

 Middle East

2 (492 vs. 753)

2.29 [1.50; 3.51]

 

Year of the study

 Before 2015

7 (3064 vs. 23,807)

1.47 [1.08; 2.02]

0.55

 2015 and after

4 (7423 vs. 70,291)

1.30 [1.01; 1.67]

 

Proportion of females

  ≥ 50%

4 (7630 vs. 70,402)

1.75 [1.30; 2.35

0.14

  < 50%

6 (2087 vs. 15,142)

1.17 [0.75; 1.84]

 

Proportion of severe disease

  ≥ 10%

6 (2376 vs. 8053)

1.49 [1.10; 2.02]

0.43

  < 10%

5 (8111 vs. 86,045)

1.25 [0.93; 1.69]

 

Not completing secondary education

 Geographic area

 Europe

8 (11,349 vs. 155,173)

1.24 [1.01; 1.53]

 

 North America

1 (124 vs. 124)

1.00 [0.14; 7.21]

0.03

 Middle East

1 (347 vs. 353)

2.14 [1.50; 3.04]

 

Year of the study

 Before 2015

5 (4150 vs. 35,173)

1.21 [0.87; 1.67]

0.34

 2015 and after

5 (7670 vs. 120,477)

1.52 [1.08; 2.14]

 

Proportion of females

  ≥ 50%

4 (7630 vs. 70,402)

1.88 [1.22; 2.89]

0.04

  < 50%

5 (2118 vs. 64,717)

1.01 [0.74; 1.40]

 

Proportion of severe disease

  ≥ 10%

6 (2478 vs. 57,839)

1.39 [0.99; 1.94]

0.77

  < 10%

4 (9342 vs. 97,811)

1.30 [1.02; 1.67]

 

Not completing vocational training

Geographic area

 Europe

6 (9693 vs. 140,872)

1.12 [1.00; 1.25]

 

 North America

1 (124 vs. 124)

0.47 [0.17; 1.31]

0.10

 Middle East

–

–

 

Year of the study

 Before 2015

3 (2267 vs. 20,866)

1.03 [0.74; 1.43]

0.43

 2015 and after

4 (7550 vs. 120,130)

1.20 [0.96; 1.51]

 

Proportion of females

  ≥ 50%

3 (7283 vs. 70,049)

1.10 [0.73; 1.65]

0.52

  < 50%

3 (462 vs. 50,416)

1.28 [1.02; 1.61]

 

Proportion of severe disease

  ≥ 10%

3 (515 vs. 50,329)

1.04 [0.65; 1.67]

0.87

  < 10%

4 (9302 vs. 90,667)

1.08 [0.97; 1.20]

Â